# LUMRYZ
> **NDA214755** · New Drug Application · Sponsor: AVADEL CNS · Approved 2023-05-01
## Drug
- **FDA Application Number:** NDA214755
- **Application type:** New Drug Application
- **Brand name:** LUMRYZ
- **Generic name:** SODIUM OXYBATE
- **Active ingredients:** SODIUM OXYBATE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AVADEL CNS
- **Manufacturer:** Avadel CNS Pharmaceuticals, LLC
- **First approval:** 2023-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214755)
---
*MORVS · CC0 1.0*